drugset / Trial / NCT06969755
Biomarkers to Enhance Early Schizophrenia Treatment
Phase 4
Recruiting
180 enrolled
Northwell Health
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is recruiting participants who are experiencing a first episode of psychosis and who have certain genetic factors that may make them respond better to certain medications that are used to treat people with psychosis.
Timeline
- Start
- 2025-09-30
- Primary completion
- 2030-07-30
- Completion
- 2030-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aripiprazole | Other / unclassified | — | — |
| Comparator | Clozapine | Other / unclassified | — | — |
| Comparator | Risperidone | Other / unclassified | — | — |